Chromatin modifications are now widely accepted as being essential steps involved in activation, repression, and poising of the expression of a large number of genes within the genome. Not only does understanding the role of such changes provide an opportunity to elucidate mechanisms controlling gene expression but in parallel offers the ability to develop novel indicative and predictive biomarkers of disease and toxicity. In the current study, we have applied the chromatin immunoprecipitation assay to investigate putative changes in the chromatin environment associated with the kidney injury molecule 1 (Kim1) gene upon exposure of rats to the nephrotoxicant, gentamicin. Chromatin was isolated from the kidneys of both control and gentamicin-treated animals and interrogated using specific antibodies recognizing two modifications of histone H3, acetylation of lysine 9, and trimethylation of lysine 4, along with RNA polymerase II. Enriched chromatin fractions were analyzed by quantitative PCR using tiled primer pairs covering 4 kb of the Kim1 gene (spanning 22 kb to 1 2 kb, relative to the transcription start site). The results demonstrate a substantial increase in the presence of RNA polymerase II and both histone modifications following gentamicin treatment in regions downstream but not upstream of the transcriptional start site of the Kim1 gene. These changes were associated with a marked increase in messenger RNA coding for the Kim1 protein. Together these data suggest, for the first time, that the Kim1 gene is regulated in an epigenetic fashion under conditions of nephrotoxicity.
The nucleosome represents the fundamental repeating unit of chromatin and consists, in its simplest form, of an octomer of two copies of each of the core histone proteins (H2A, H2B, H3, and H4) along with~147 bp of DNA. Although the majority of the tertiary structure of each histone protein is tightly organized in a globular fashion, the N-terminal regions of these polypeptides are unstructured. These ''tails'' contain many amino acids that have been shown to be subject to posttranslational modifications, including acetylation, methylation, phosphorylation, and ubiquitylation (Kouzarides, 2007) . Moreover, each of these residue-specific modifications, either alone or in combination, can provide critical binding sites that allow the recruitment of various enzymes involved in regulation of DNAbased processes (Jenuwein and Allis, 2001; Kouzarides, 2007) . With regard to transcription, much work has been conducted in defining the roles of a number of modifications in the processes of transcriptional activation and repression. For example, both the acetylation of histone H3 on lysine 9 and trimethylation of histone H3 on lysine 4 are thought to play roles in transcriptional activation of certain genes (Agalioti et al., 2002; Sims et al., 2007) .
From a toxicological perspective, profiling epigenetic histone marks both on a genetic and genomic scale, offers the opportunity to elucidate mechanisms controlling stress or toxicity-induced transcriptional changes and provides a wealth of new possibilities for the development of biomarkers (Marlowe et al., 2009) . To this end, the present study focused on exploring toxicoepigenetic changes in a 4-kb region of the kidney injury molecule 1 (Kim1) gene in rats treated with the nephrotoxicant, gentamicin. Functionally, Kim1 is a receptor for phosphotidylserine that is present on the cell surface of apoptotic kidney epithelial cells following tissue injury. This confers a phagocytic phenotype on Kim1 expressing cells, allowing them to engulf and thereby remove neighboring dying and damaged cells (Ichimura et al., 2008) . Transcription of Kim1 is highly upregulated in rats exposed to classical nephrotoxicants (Hubank and Schatz, 1994; Ichimura et al., 1998 , Amin et al., 2004 although little is known regarding the molecular mechanisms governing this transcriptional change. Moreover, detection of Kim1 protein in the urine appears to provide a means of monitoring for nephrotoxicity that is substantially more sensitive and specific than existing biomarkers (Bonventre, 2009) The current study demonstrates for the first time that upregulation of Kim1 expression, following chemically induced kidney damage, involves changes in specific histone modifications within the coding region of the gene. These changes are correlated with recruitment of RNA polymerase II (Pol II), again to the coding regions of the gene, and provide insight into the molecular mechanisms governing gentamicin/ nephrotoxicant-induced transcription of Kim1.
MATERIALS AND METHODS
Animals and treatment. Male Sprague-Dawley (Crl:CD(SD)(IGS)BR) rats at 7 weeks of age were purchased from Charles River Laboratories. Housing and treatment of the animals were in accordance with the USDA Animal Welfare Act. Animals were subcutaneously administered either 267 mg/kg/day gentamicin (Sigma) in corn oil or corn oil alone (vehicle control) for five consecutive days and killed 24 h following the final dose.
Clinical and histological evaluation. Gross necropsy observations, organ weights, body weights, clinical chemistry, and histopathological data were collected as described (Ganter et al., 2005) .
RNA isolation and quantitative PCR. Total RNA was extracted from kidney samples using the RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions. The quality and quantity of the purified RNA were determined with an RNA 6000 Nano kit using the 2100 Bioanalyzer Lab-on-aChip system (Agilent Technologies). Total RNA was converted to complementary DNA (cDNA) utilizing the TaqMan Reverse Transcription Reagents Kit from Applied Biosystems according to the manufacturer's instructions. Quantitative PCR (qPCR) was conducted using a reaction containing 20 ng of cDNA (based on the assumption that conversion of RNA to cDNA was 100% successful) 13 SYBR green PCR master mix (Applied Biosystems) and either 100nM (18S) or 200nM (all Kim1) forward and reverse oligonucleotides. Primer pairs for analysis of Kim1 expression were described previously (Wang et al., 2008) . Samples were assembled using a Biomek NX robot (Beckman Coulter) and analyzed using an Applied Biosystems 7900HT real-time PCR system (Applied Biosystems); 18S was used to control for the amount of RNA present in each sample.
Chromatin immunoprecipitation. Chromatin immunoprecipitation (ChIP) assays were conducted using a procedure based upon a previously published protocol (Nelson et al., 2006) . Briefly, 200-300 mg of frozen kidney tissue was ground to a fine powder in liquid nitrogen and transferred to a 50-ml tube and allowed to dry. Immediately following the evaporation of liquid nitrogen, the ground tissue was suspended in fixation solution (1% [vol/vol] formaldehyde (Pierce Biotechnology) in Dulbecco's modified Eagle's medium (Invitrogen); 1 ml/40 mg of tissue) and incubated for 15 min at room temperature. Fixation was stopped by the addition of glycine (Sigma) to a final concentration of 125mM and further incubation of the sample at room temperature for 5 min. Fixed cells were collected by centrifugation of the sample at 2000 3 g for 5 min at 4°C and washed twice with PBS before being frozen at À80°C until required. Next, the frozen cell pellet was thawed on ice and resuspended in 100 ll of immunoprecipitation (IP) buffer (150mM NaCl, 50mM Tris-HCl (pH 7.5), 5mM EDTA, NP-40 (0.5% vol/vol), Triton X-100 [1.0% vol/vol]) containing protease inhibitors per 20 mg of tissue. The suspension was subsequently centrifuged at 12,000 3 g for 1 min at 4°C, the supernatant was aspirated, and the pellet was again resuspended in IP buffer and centrifuged as described above. Following washing, the cell pellet was resuspended in 100-ll IP buffer/20-mg tissue and sonicated 8 3 15 s at 100% amplitude using a Sonics Vibra-Cell VCX130 sonicator and insoluble material was removed by centrifugation of the sample for 10 min at 12,000 3 g, 4°C.
Shearing efficiency was determined by removing an aliquot of sonicated chromatin, adding 2.5 volumes of 100% ethanol and centrifuging at 12,000 3 g for 10 min at 4°C to collect the precipitated DNA. The DNA pellet was washed once with 70% ethanol, then dissolved in 100 ll of 10% (wt/vol) Chelex 100 (Sigma) and heated to 99°C for 10 min. The sample was cooled to room temperature; 20 lg of proteinase K (Sigma) was added, and a 30-min incubation was performed at 55°C in a shaking heating block (set to 1000 revolutions per minute [rpm] ). Subsequently, proteinase K was inactivated by heating the sample to 99°C for 10 min, and the DNA suspension was recovered following removal of Chelex by centrifuging at 12,000 rpm for 1 min at 4°C. DNA size was determined by standard agarose gel electrophoresis (we routinely observed DNA sheared to 300 bp) and quantity/quality assessed by absorption of light at 260 and 280 nm.
IP , Millipore] ). Samples were incubated at 4°C overnight with rotation, then they were cleared by centrifugation at 12,000 3 g for 10 min at 4°C, and the top 90% of the supernatant was decanted to a fresh microcentrifuge tube. Protein A agarose beads (Millipore) were washed three times with 1-ml IP buffer to remove ethanol and resuspended at a ratio of 1:1 with IP buffer. About 40 ll of the bead solution was added to each IP and the samples were rotated at 4°C for 45 min. Subsequently, beads were washed six times with 1 ml of ice-cold IP buffer, and 100 ll of 10% (wt/vol) Chelex 100 slurry was added and samples were vortexed and incubated at 99°C for 10 min.
DNA concentration was determined using the Nanodrop 8000 spectrophotometer (Fisher Scientific), and qPCR reactions were conducted in a 25-ll volume containing 125-ng DNA, 1 3 SYBR green PCR mastermix (Applied Biosystems), and 200nM forward/reverse primers using an Applied Biosystems 7900HT real-time PCR system (Applied Biosystems). All primer pairs were purchased from SABiosciences (ChIP-qPCR primers). The relative occupancy of the immunoprecipitated factor at a locus is estimated using the following equation: 2^(CtIgG -Ctspecific), where CtIgG and Ctspecific are mean threshold cycles of PCR done in triplicate on DNA samples from control IgG and specific antibody IPs (Nelson et al., 2006) .
RESULTS

Exposure of Male Spague-Dawley Rats to Gentamicin Results
in a Substantial Increase in Kim1 mRNA Correlated with Histopathological Renal Changes Male Sprague-Dawley rats were subcutaneously administered either 267 mg/kg/day gentamicin in corn oil or corn oil alone (vehicle control) for five consecutive days and killed 24 h following the final dose. This study design (i.e., dose and duration of treatment) was selected based upon previous dose range finding experiments in which expression of Kim1 was found to be robustly increased and histopathological changes were evident at the end of the treatment period (Fielden et al., 2005; Wang et al., 2008) . Microscopic examination of the kidneys of all study animals revealed that all three gentamicintreated rats had moderate to severe proximal tubule necrosis, a finding not observed in control animals (Supplementary fig. 1 ).
Subsequently, messenger RNA (mRNA) levels of the nephrotoxicity biomarker Kim1 were measured by qPCR in kidney tissue derived from vehicle-and gentamicin-treated animals. A marked increase (average~1500-fold) in Kim1 mRNA was observed in the rats exposed to the nephrotoxicant ( Fig. 1 and Supplementary fig. 1 ). These data are consistent with previously published studies and are in-line with the notion that transcription of Kim1 is markedly increased during 376 CHEN ET AL. kidney injury (Hubank and Schatz, 1994; Ichimura et al., 1998 , Amin et al., 2004 .
Increased Transcription of the Kim1 Gene is Associated With Epigenetic Posttranslational Modification of Key Histone Proteins During Nephrotoxicity
Although it is clear that transcriptional upregulation of Kim1 expression is a hallmark of kidney injury, the molecular mechanisms governing this expression change are poorly characterized. Therefore, the aim of the present study was to elucidate chromatin-based alterations, which may play a role in mediating nephrotoxicant-mediated induction of the Kim1 gene.
Frozen kidney tissue, from both vehicle-and gentamicintreated rats (described in the preceding section), was finely ground and then subjected to covalent cross-linking using formaldehyde. DNA from the samples was sonicated to an average size of~300 bp and then interrogated using the ChIP assay. Three factors were focused on: Pol II, acetylation of histone H3 on lysine 9 (H3 AcK9), and trimethylation of histone H3 on lysine 4 (H3 Me(3)K4). Prior to analyzing the Kim1 gene, an assessment of the specificity of the antibodies used in the study was made. Chromatin prepared from the kidneys of vehicle-treated animals was subjected to IP using either specific antibodies recognizing Pol II, H3 AcK9, and H3 Me(3)K4 or an isotype control IgG. DNA recovered from the reactions was analyzed by qPCR using primers specific for the þ 1 kb (relative to the transcription start site) regions of Cd4, myogenic differentiation 1 (Myod1) (both expressed at very low levels in the kidney), and poly(A)-binding protein, cytoplasmic 1 (Pabpc1) (a highly expressed gene) (Fig. 2) . These data demonstrated that all three factors were substantially more abundant on Pabpc1 than either Cd4 or Myod1: Pol II occupancy was 4-or 12.5-fold higher than on Cd4 or Myod1, respectively; H3 AcK9 occupancy was 6-or 12.5-fold higher than on Cd4 or Myod1, respectively; and H3 Me(3)K4 was 10.5 or 239-fold higher than on Cd4 or Myod1, respectively (Fig. 2) . Therefore, this result supports the specificity of the antibodies being used and emphasizes the role of the factors examined in mediating high-level gene expression.
Next, the same antibodies were used to immunoprecipitate chromatin derived from the kidneys of both vehicle-and gentamicin-treated rats. Isolated DNA was analyzed by qPCR using primer pairs specific for the À2 kb, À1 kb, þ 1 kb, and þ 2 kb (relative to the transcription start site) regions of the Kim1 gene. As shown in Figure 3A -C, following gentamicin treatment, a large increase (~10-fold) in H3 Me(3)K4 was observed in regions downstream but not upstream of the Kim1 transcriptional start site (Fig. 3A) . Levels of this modification were constant across the region examined in tissue from vehicle-treated animals. Similarly, an increase in the occupancy of H3 AcK9, downstream but not upstream of the transcriptional start site, was observed in kidney tissue from gentamicintreated animals relative to those administered vehicle alone (Fig. 3B) . These data strongly suggest that H3 Me(3)K4 and H3 AcK9 represent critical chromatin marks that facilitate binding of the transcriptional machinery to Kim1 and activation of gene expression. To test this hypothesis further, recruitment of Pol II to Kim1 was also analyzed (Fig. 3C) . Increased occupancy of Pol II was noted in the þ 1 kb and þ 2 kb, but not the À1 kb and À2 kb regions of Kim1 in chromatin derived from the kidneys of gentamicin-treated rats compared with that from vehicle control animals (Fig. 3C) , confirming that the aforementioned histone modifications provide an environment on Kim1 that is permissive to active transcription. As a control, the þ 1 kb region of both the Pabpc1 and Cd4 genes were FIG. 1. Kim1 mRNA levels are substantially elevated in rats administered gentamicin. Male Sprague-Dawley rats (n ¼ 3) were subcutaneously administered either 267 mg/kg/day gentamicin in corn oil or corn oil alone (control) for five consecutive days and killed 24 h following the final dose. RNA was subsequently extracted from kidney tissue derived from treated animals and changes in Kim1 mRNA levels were determined by qPCR. Ribosomal 18S RNA levels were used as an internal control. Average fold change in gene expression is shown for each group þ SEM.
FIG. 2.
RNA Polymerase II, H3 AcK9, and H3 Me(3)K4 are more abundant on highly expressed genes. Kidney tissue derived from control rats was subjected to covalent cross-linking using formaldehyde. Following sonication, the resulting chromatin was immunoprecipitated using the antibodies indicated or isotype control IgG. Recovered DNA was analyzed by qPCR for the specified genes. The average occupancy of each factor relative to IgG control is shown, n ¼ 3. Data shown are average þ SEM.
TOXICOEPIGENETIC ALTERATION OF KIM1
analyzed using the same IP DNA samples utilized for detection of the Kim1 gene. In both cases, no change in the occupancies of Pol II, H3 AcK9, or H3 Me(3)K4 were observed (Figs. 4A and B) when chromatin from vehicle-and gentamicin-treated animals was compared, indicating that the alterations observed on Kim1 do not represent a genome-wide phenomenon. Individual animal data for each of the parameters examined is shown in Supplementary figure 1. Altogether, these results strongly indicate that epigenetic reprogramming plays a central role in mediating increased Kim1 expression during nephrotoxicity.
DISCUSSION
It is becoming increasingly well accepted that Kim1 represents a highly sensitive and specific biomarker for nephrotoxicity (Bonventre, 2009 ). However, the molecular mechanisms governing the induction of this gene during kidney injury are ill-defined. By profiling epigenetic changes on the Kim1 gene, this study has provided the first insight into the molecular mechanisms controlling its induction. Specifically, the data presented in this report show that histone H3 K9 acetylation and histone H3 K4 trimethylation are both notably increased in a 2 kb region downstream of the Kim1 transcriptional start site. Functionally, these modifications are known to play key roles in the expression of certain genes. For example, with regard to H3 AcK9, a series of elegant experiments demonstrated that this modification is essential for recruitment of TFIID to the interferon-b (IFN-b) promoter by an enhanceosome transcription factor complex comprising ATF-2/c-Jun, IRF-3/IRF-7, and NFjB (Agalioti et al., 2002) . Following virus infection, these factors bind the IFN-b promoter, recruit histone acetyl transferase coactivator proteins, which in turn can acetylate histone H3 on lysine 9 and facilitate TFIID recruitment. The largest subunit contained within the TFIID complex is known   FIG. 3 . Increased occupancy of H3 Me(3)K4, H3 AcK9, and RNA Polymerase II is observed downstream of the Kim1 transcriptional start site in gentamicintreated rats. Kidney tissue derived from both control-and gentamicin-treated rats was subjected to covalent cross-linking using formaldehyde. Fixed chromatin was sheared by sonication and immunoprecipitated with each of the following antibodies: anti-H3 Me(3)K4 (A), anti-H3 AcK9 (B), anti-RNA Pol II (C); and isotype control IgG. Recovered DNA was analyzed by qPCR using primer pairs specific for the À2, À1, þ 1, and þ 2-kb (relative to the transcription start site) regions of Kim1. The average occupancy of each factor relative to IgG control is depicted, n ¼ 3. Data shown are average ± SEM. 378 CHEN ET AL.
as TAFII250 and contains two bromodomains that confer the ability to recognize and bind to H3 AcK9 (Agalioti et al., 2002) . H3 Me(3)K4 by contrast has been shown to play a role in the recruitment of pre-mRNA splicing factors to specific actively transcribed genes (Sims et al., 2007) . This is accomplished through recognition and binding of Me(3)K4 by the chromodomain of CHD1 that in turn interacts with key components of the splicing machinery and thereby affects efficient gene expression. These examples raise the intriguing possibility that H3 AcK9 and H3 Me(3)K4 on the Kim1 gene may fulfill similar roles, that is, facilitating the recruitment of TFIID and pre-mRNA splicing factors. This is further backed by the fact that these posttranslational modifications were found within the transcribed region of the gene. However, determining the exact role(s) of these posttranslational modifications require additional experimentation, and it may be that these changes play distinct roles from those described in the examples above. Moreover, a major outstanding question is what comprises the transcriptional complex that binds to and activates Kim1 expression during nephrotoxicity. Answering this question may provide insight into both upstream processes governing Kim1 activation and shed light on the enzymatic process involved in modification of histone residues within the coding region. Overall, the data provided in the present study have given an initial insight into how Kim1 is upregulated in the damaged kidney and provided a platform for further elucidation of this mechanism.
The process of epigenetic profiling used in the current study is not only useful for answering specific mechanistic questions but is also more broadly applicable to the realm of biomarkers. Indeed, alterations in both histone modifications and DNA methylation are now widely accepted as central events in the transformation of cells to a malignant phenotype (MuleroNavarro and Esteller, 2008) . Moreover, these changes to the chromatin environment are now being utilized in a clinical setting particularly in the area of oncology. For example, there exist specific epigenetic markers, currently being validated, which may allow (1) early detection of various forms of cancer, (2) determination of the likely progression of a particular tumor, and (3) prediction of the response of the cancer to treatment (Mulero-Navarro and Esteller, 2008) . In the field of toxicology, these approaches may yield valuable information regarding the propensity of any given drug development candidate to cause defined toxicities. An illustration of this is represented by the two-year rodent carcinogenesis studies that are currently a regulatory requirement but clearly have considerable cost and time implications. Epigenetic profiling could be utilized to define early events in the development of cancer in rodents thus allowing early prediction of the outcome of carcinogenesis studies (Moggs et al., 2004; Marlowe et al., 2009) . Moreover, there is also evidence that many epigenetic changes function to form a memory of prior gene expression alterations, that is, a particular histone or DNA modification may not correlate with concurrent transcriptional alterations but rather provide the cell with the knowledge that a given gene was activated previously and provide a mechanism for subsequent rapid restimulation. This phenomenon is evident in immune function where, for example, genes encoding IL-2 and IFNc can be epigenetically imprinted to create an environment for enhanced responsiveness during additional rounds of stimulation in CD8 T cells (Northrop et al., 2006) . Detection and definition of such changes again provide opportunities to develop safety biomarkers, uncover potential liabilities, and investigate mechanisms of toxicity.
In summary, the current study has elucidated key epigenetic changes in the Kim1 gene that correlate with its transcriptional   FIG. 4 . Occupancy of H3 Me(3)K4, H3 AcK9, and RNA Polymerase II on Pabpc1 and Cd4 is not altered following gentamicin treatment of rats. Kidney tissue derived from both control-and gentamicin-treated rats was fixed using formaldehyde. Cross-linked chromatin was sheared by sonication and immunoprecipitated with each of the following antibodies: anti-H3 Me(3)K4, anti-H3 AcK9, anti-RNA Pol II, and isotype control IgG. Isolated DNA was interrogated by qPCR using primer pairs specific for the þ 1-kb (relative to the transcription start site) regions of Pabpc1 (A) and Cd4 (B). Note that the same batch of DNA used to generate the data for Figure 3 was used in this experiment. The average occupancy of each factor relative to IgG control is depicted, n ¼ 3. Data shown are average þ SEM.
TOXICOEPIGENETIC ALTERATION OF KIM1 379 activation during nephrotoxicity. These experiments have provided a basis for further definition of the processes governing Kim1 transcription and provide insight into the potential for epigenetic profiling more generally within risk assessment.
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